DARPA has extended its engagement with Kromek into a new market segment. Kromek's Sigma platform now incorporates biological threat detection and the product has a meaningful competitive advantage. The proof of concept contract could possibly be extended in our opinion. This further raises revenue visibility and underpins our Buy recommendation.
10 Dec 2018
Cenkos: Kromek Group Plc - A new market segment
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Kromek Group Plc - A new market segment
Kromek Group Plc (KMK:LON) | 7.2 0 (-2.1%) | Mkt Cap: 45.8m
- Published:
10 Dec 2018 -
Author:
Cavendish Research -
Pages:
6
DARPA has extended its engagement with Kromek into a new market segment. Kromek's Sigma platform now incorporates biological threat detection and the product has a meaningful competitive advantage. The proof of concept contract could possibly be extended in our opinion. This further raises revenue visibility and underpins our Buy recommendation.